Cargando…

Polygenic heterogeneity in antidepressant treatment and placebo response

The genetic architecture of antidepressant response is poorly understood. Polygenic risk scores (PRS), exploration of placebo response and the use of sub-scales might provide insights. Here, we investigate the association between PRSs for relevant complex traits and response to vortioxetine treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nøhr, Anne Krogh, Forsingdal, Annika, Moltke, Ida, Howes, Oliver D., Vitezic, Morana, Albrechtsen, Anders, Dalby, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617908/ https://www.ncbi.nlm.nih.gov/pubmed/36309483 http://dx.doi.org/10.1038/s41398-022-02221-4

Ejemplares similares

A large-scale genome-wide gene expression analysis in peripheral blood identifies very few differentially expressed genes related to antidepressant treatment and response in patients with major depressive disorder
por: Nøhr, Anne Krogh, et al.
Publicado: (2021)

NGSremix: a software tool for estimating pairwise relatedness between admixed individuals from next-generation sequencing data
por: Nøhr, Anne Krogh, et al.
Publicado: (2021)

Allele frequency‐free inference of close familial relationships from genotypes or low‐depth sequencing data
por: Waples, Ryan K., et al.
Publicado: (2019)

Calculation of Tajima’s D and other neutrality test statistics from low depth next-generation sequencing data
por: Korneliussen, Thorfinn Sand, et al.
Publicado: (2013)

Neural Predictors of the Antidepressant Placebo Response
por: Rette, Danielle, et al.
Publicado: (2019)

Highly polygenic architecture of antidepressant treatment response: Comparative analysis of SSRI and NRI treatment in an animal model of depression
por: Malki, Karim, et al.
Publicado: (2016)

Antidepressants and the Placebo Effect
por: Kirsch, Irving
Publicado: (2014)

Antidepressants for smoking cessation
por: Hajizadeh, Anisa, et al.
Publicado: (2023)

Genetic Loss of Sucrase-Isomaltase Function: Mechanisms, Implications, and Future Perspectives
por: Senftleber, Ninna Karsbæk, et al.
Publicado: (2023)

Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohorts
por: Ward, Joey, et al.
Publicado: (2018)

Asap: A Framework for Over-Representation Statistics for Transcription Factor Binding Sites
por: Marstrand, Troels T., et al.
Publicado: (2008)

Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
por: Camacho, Mariam B., et al.
Publicado: (2017)

Archaic Adaptive Introgression in TBX15/WARS2
por: Racimo, Fernando, et al.
Publicado: (2017)

Challenging Received Wisdom: Antidepressants and the Placebo Effect
por: Kirsch, Irving
Publicado: (2008)

Understanding the Neurocomputational Mechanisms of Antidepressant Placebo Effects
por: Peciña, Marta, et al.
Publicado: (2021)

Reduced signal for polygenic adaptation of height in UK Biobank
por: Berg, Jeremy J, et al.
Publicado: (2019)

Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report
por: Singh, Ajeet B.
Publicado: (2015)

Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective
por: Wendt, Frank R., et al.
Publicado: (2020)

Accounting for symptom heterogeneity can improve neuroimaging models of antidepressant response after electroconvulsive therapy
por: Wade, Benjamin S. C., et al.
Publicado: (2021)

Disclosing the potential impact of placebo controls in antidepressant trials
por: Chen, Stephanie C., et al.
Publicado: (2015)

Prefrontal expectancy and reinforcement-driven antidepressant placebo effects
por: Peciña, M., et al.
Publicado: (2018)

Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
por: Brown, Vanessa, et al.
Publicado: (2019)

Polygenic Heterogeneity Across Obsessive-Compulsive Disorder Subgroups Defined by a Comorbid Diagnosis
por: Strom, Nora I., et al.
Publicado: (2021)

Characterizing mood disorders in the AFFECT study: a large, longitudinal, and phenotypically rich genetic cohort in the US
por: Dalby, Maria, et al.
Publicado: (2022)

GENOME-WIDE META-ANALYSIS SUPPORTS HETEROGENEITY IN POLYGENIC ARCHITECTURE OF DISABILITY
por: Kulminski, Alexander, et al.
Publicado: (2019)

Re-evaluation of Significance and the Implications of Placebo Effect in Antidepressant Therapy
por: Curkovic, Marko, et al.
Publicado: (2019)

Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
por: Curkovic, Marko, et al.
Publicado: (2019)

Potential of Heterogeneous Compounds as Antidepressants: A Narrative Review
por: Hu, Gonghui, et al.
Publicado: (2022)

Dissecting clinical heterogeneity of bipolar disorder using multiple polygenic risk scores
por: Coombes, Brandon J., et al.
Publicado: (2020)

Identification of Novel Genetic Determinants of Erythrocyte Membrane Fatty Acid Composition among Greenlanders
por: Andersen, Mette Korre, et al.
Publicado: (2016)

Multi-PGS enhances polygenic prediction by combining 937 polygenic scores
por: Albiñana, Clara, et al.
Publicado: (2023)

Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
por: Hill, Kathryn R., et al.
Publicado: (2021)

A Polygenic Approach to the Study  of Polygenic Diseases
por: Lvovs, D., et al.
Publicado: (2012)

Evaluation of Quantitative EEG by Classification and Regression Trees to Characterize Responders to Antidepressant and Placebo Treatment
por: Rabinoff, M, et al.
Publicado: (2011)

PS79. Gender differences in sunshine increased antidepressant placebo effect
por: Gailledreau, Joël, et al.
Publicado: (2016)

The Efficacy and Heterogeneity of Antipsychotic Response in Schizophrenia: A Meta-analysis
por: McCutcheon, Robert A., et al.
Publicado: (2021)

RECLU: a pipeline to discover reproducible transcriptional start sites and their alternative regulation using capped analysis of gene expression (CAGE)
por: Ohmiya, Hiroko, et al.
Publicado: (2014)

T45. THE EFFICACY AND HETEROGENEITY OF ANTIPSYCHOTIC RESPONSE IN SCHIZOPHRENIA: A META-ANALYSIS
por: McCutcheon, Rob, et al.
Publicado: (2020)

Leveraging correlations between variants in polygenic risk scores to detect heterogeneity in GWAS cohorts
por: Yuan, Jie, et al.
Publicado: (2020)

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9fi90oekhf7o6rrmn0307568oo